Zhangzhou Pientzehuang Pharmaceutical | 600436 - Betriebsaufwand

Aktienkurs
152.69
Täglich Wechseln
0.63 0.41%
Monatlich
-7.95%
Jährlich
-25.94%
Q1 Prognose
152.81




Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Cspc Pharmaceutical CNY 5.4B 298.41M 2025-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Jiangsu Hengrui CNY 5.94B 254.97M 2025-09
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Moderna USD 1.54B 259M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Sh Fosun Pharma CNY 9.12B 194.06M 2025-09
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.86B 335.7M 2025-12
Wuxi Apptec CNY 7.84B 354.28M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09